Latest stories on AAPG
Ascentage Pharma (AAPG) Reports Phase 1b Olverembatinib Data
Yahoo Top58 · neutralproduct/pr
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026 | AAPG Stock News
StockTitan67 · bullishproduct/pr
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026 | AAPG Stock News
StockTitan58 · neutralproduct/pr